Impact of Clinical Syndrome Acuity on the Differential Response to 2 Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Coronary Stenting: The TARGET Trial*
暂无分享,去创建一个
E. Topol | G. Stone | C. Grines | F. Neumann | J. Moses | M. Bertrand | H. Herrmann | D. Cohen | D. Moliterno | K. Wolski | E. Powers | Marc Cohen | E. Cohen | P. Dibattiste | D. Cohen | Peter M Dibattiste